Abbott Finally Joins MRI-Compatibility Club In US CRM Market

The firm’s Assurity MRI pacemaker and Tendril MRI pacing lead, acquired in its recent St. Jude Medical deal, gained US FDA approval after some delay. Lack of this designation has been a competitive challenge for the business in the past year.

Abbott Laboratories Inc. shed a significant drag on its efforts to pick up market-share in the US cardiac rhythm management market with the Feb.1 FDA approval of MRI-conditional labeling for its pacemakers.

Abbott’s CRM business, which it acquired on Jan. 4 as part of its acquisition of St. Jude Medical Inc., fell behind competitors in achieving labeling to support use of...

More from Cardiology

More from Device Area